Cross‐regulation between β1‐ and β3‐adrenoceptors following chronic β‐adrenergic stimulation in neonatal rat cardiomyocytes
Authors:
- 25 August 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (1) , 300-313
Abstract
Background and purpose: We have previously shown that β‐adrenoceptors continuously stimulated with noradrenaline induces an increase in β3‐adrenoceptors (GαiPCRs) and a decrease in β1‐adrenoceptors (GαsPCRs) at functional, genomic and protein levels. This compensatory modification induced by noradrenaline is probably one of the consequences of cardiac depression observed in heart disease. Therefore, we investigated further the interaction between β1‐ and β3‐adrenoceptors in neonatal rat cardiomyocytes.Experimental approach: Functional studies were performed by cyclic adenosine monophosphate (cAMP) accumulation assays in cells untreated or treated with dobutamine and ICI 118551 (β1‐adrenoceptor) or CL‐3162436243 (β3‐adrenoceptor) for 24 h in the presence or absence of protein kinase inhibitors. β‐adrenoceptor and protein kinase expression was monitored by quantitative reverse transcription‐polymerase chain reaction (RT‐PCR) and by Western blotting, respectively.Key results: Chronic β1‐ or β3‐adrenoceptor stimulation reduced β1‐adrenoceptor‐mediated cAMP accumulation in association with a decrease in β1‐adrenoceptor mRNA and protein levels through protein kinase C (PKC), phosphoinositide 3‐kinase (PI3K) and p38 mitogen‐activated protein kinase (p38MAPK) activation. In contrast, both treatments induced an increase in β3‐adrenoceptor expression and β3‐adrenoceptor‐inhibited forskolin response through PKC, extracellular‐signal‐regulated kinases 1 and 2 (ERK1/2) and p38MAPK phosphorylation, although no β3‐adrenoceptor response was observed in untreated cells. ERK1/2 and p38MAPK were activated by both treatments. The modulation of β1‐ or β3‐adrenoceptor function did not require stress‐activated protein kinase/c‐Jun N‐terminal kinase (SAPK/JNK) although chronic β1‐adrenoceptor stimulation activated SAPK/JNK. β3‐adrenoceptor treatment activated Akt although PI3K was not involved in β3‐adrenoceptor up‐regulation.Conclusion and implications: We show for the first time that chronic β1‐ or β3‐adrenoceptor stimulation leads to the modulation of β1‐ and β3‐adrenoceptors by a cross‐regulation involving PKC, PI3K p38MAPK and MEK/ERK1/2 pathway, and through protein kinase A when β1‐adrenoceptors are chronically activated.Keywords
This publication has 48 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Endocytosis machinery is required for β1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytesCardiovascular Research, 2008
- Inhibition of p38α MAPK rescues cardiomyopathy induced by overexpressed β2-adrenergic receptor, but not β1-adrenergic receptorJournal of Clinical Investigation, 2007
- Cardiac GPCRs: GPCR signaling in healthy and failing heartsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Induction of β3-Adrenergic Receptor Functional Expression following Chronic Stimulation with Noradrenaline in Neonatal Rat CardiomyocytesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- MAP kinases as structural adaptors and enzymatic activators in transcription complexesJournal of Cell Science, 2004
- Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Anti-obesity and anti-diabetic effects of CL 316, 243, a highly specific β3-adrenoceptor agonist, in yellow KK miceLife Sciences, 1994
- Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shockCritical Care Medicine, 1993
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984